These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30146577)

  • 1. The Progression of Esophageal Mucosa-associated Lymphoid Tissue Lymphoma after Helicobacter pylori Eradication Therapy: A Case Report and Discussion of Therapeutic Options.
    Takeuchi Y; Miyahara K; Morito T; Okikawa Y; Kinugasa H; Moritou Y; Higashi R; Kunihiro M; Nakagawa M
    Intern Med; 2019 Jan; 58(2):207-212. PubMed ID: 30146577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review.
    Abbas H; Niazi M; Makker J
    Am J Case Rep; 2017 May; 18():491-497. PubMed ID: 28469125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
    Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of superficial gastric MALT lymphoma with unsuccessful eradication therapy for Helicobacter pylori infection.
    Yoshikane H; Yokoi T; Hidano H; Sakakibara A; Niwa Y; Goto H
    J Gastroenterol; 1997 Dec; 32(6):812-6. PubMed ID: 9430022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
    Asano N; Iijima K; Terai S; Jin X; Ara N; Chiba T; Fushiya J; Koike T; Imatani A; Shimosegawa T
    Tohoku J Exp Med; 2012 Nov; 228(3):223-7. PubMed ID: 23076291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
    Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
    J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasmacytic differentiation in gastric mucosa-associated lymphoid tissue lymphomas: Helicobacter pylori eradication response and IgG4+ plasma cell association.
    Park S; Ahn S; Hong M; Ko YH
    Hum Pathol; 2017 Jan; 59():113-119. PubMed ID: 27697589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
    Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
    Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
    Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy.
    Caletti G; Togliani T; Fusaroli P; Sabattini E; Khodadadian E; Gamberi B; Gobbi M; Pileri S
    Gastroenterology; 2003 Feb; 124(2):537-43. PubMed ID: 12557157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric MALT-lymphoma, gastrin and cyclooxygenases.
    Konturek PC; Konturek SJ; Pierzchalski P; Starzyńska T; Marlicz K; Hartwich A; Zuchowicz M; Darasz Z; Papiez D; Hahn EG
    Acta Gastroenterol Belg; 2002; 65(1):17-23. PubMed ID: 12014312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
    Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A;
    Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.